Your browser doesn't support javascript.
loading
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer.
Hinneh, Josephine A; Gillis, Joanna L; Mah, Chui Yan; Irani, Swati; Shrestha, Raj K; Ryan, Natalie K; Atsushi, Enomoto; Nassar, Zeyad D; Lynn, David J; Selth, Luke A; Kato, Masashi; Centenera, Margaret M; Butler, Lisa M.
Afiliação
  • Hinneh JA; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Gillis JL; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Mah CY; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Irani S; Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Shrestha RK; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia.
  • Ryan NK; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Atsushi E; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Nassar ZD; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia.
  • Lynn DJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Selth LA; Freemason's Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Kato M; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Centenera MM; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5005, Australia.
  • Butler LM; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, 5000, Australia.
Br J Cancer ; 129(8): 1350-1361, 2023 10.
Article em En | MEDLINE | ID: mdl-37673961

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2023 Tipo de documento: Article